
China's central bank left the one-year LPR at 3.00% and the five-year LPR at 3.50% in November, the sixth consecutive monthly hold and in line with market expectations. The steady fixings, together with the PBOC's reintroduction of 'cross‑cyclical' policy language and a recent US‑China trade truce, signal a reduced urgency for broad-based monetary easing despite mounting downside risks. October data showing contracting exports, slowing retail sales and a sharp drop in new bank lending have weighed on growth, and Goldman Sachs notes the PBOC appears willing to tolerate weaker loan growth, pushing back forecasts for a dual policy-rate and RRR cut to Q1 2026.
China's central bank left the one-year LPR at 3.00% and the five-year LPR at 3.50% in November, marking the sixth consecutive monthly hold and matching a Reuters survey of 23 participants that all expected no change. The decision signals the PBOC's current stance to avoid immediate rate cuts despite a weaker outlook. The PBOC has reintroduced "cross-cyclical" policy language in its third-quarter implementation report — the first mention since Q1 last year — and the article links this shift to a reduced urgency for broad-based easing even after a recent U.S.-China trade truce that included tariff trimming in exchange for China cracking down on illicit fentanyl, resuming U.S. soybean purchases and keeping rare earths exports flowing. Analysts note the central bank appears willing to tolerate slower loan growth rather than deploy blanket monetary stimulus. October macro data showed a contraction in exports, a further slowdown in retail sales and a sharp fall in new bank lending that missed expectations, indicating rising downside risks to growth. Goldman Sachs explicitly pushed back its forecast for a dual policy-rate and RRR cut to Q1 2026, implying lower near-term probability of monetary support and potential continued pressure on credit-sensitive sectors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment